UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.

Assessment of psilocybin therapy for patients with cancer and major depression disorder

15/04/2023 15/04/2023

Assessment of psilocybin therapy for patients with cancer and major depression disorder

This study uses a potentially more efficient/cost-effective 1-to-1 (rather than the currently standard 2-to-1) therapist-to-patient ratio.

16/01/2023 16/01/2023

Is the high cost of psychedelic therapy worth it?

In this column I will examine the costs and benefits of psychedelic-assisted therapy,

10/12/2022 10/12/2022

The economics of psychedelic-assisted therapies: A research agenda

We describe six types of economic analyses and their rationale for decisions and planning including the needs of health care payers.